how much glp 1 is in tirzepatide Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Compound Tirzepatide

A 5 mg vial reconstituted to 2.5 mg/mL contains roughly 20 weeks of 0.25 mg starting doses or 10 weeks of 0.5 mg, dropping to 2 weeks at the top 2.4 mg dose

Their effectiveness, regarding reduction of hyperglycemia, has been demonstrated in multiple trials and the class is extensively utilized in the treatment of patients with DM2 and cardiovascular disease

Melissa G

They make you feel very comfortable

Alternatively, semaglutide 2.4 mg (Wegovy) is recommended by NICE (TA875) for weight management only within specialist weight management services for people meeting specific BMI and comorbidity criteria

Safety and Side Effects Many people starting Wegovy (semaglutide) for weight management wonder whether they need to give up their daily coffee